Sexual functionality significantly contributes to health-related quality of life and can decrease with obesity. In this study, we aimed to prospectively evaluate the changes that occur in the erection function, sexual function and testosterone level of male patients scheduled to undergo bariatric surgery, as well as the changes in the sexual function of their partner. A total of 40 patients and their partners were included. International Index of Erectile Function-5 (IIEF-5) questionnaire and the Arizona Sexual Experience Scale (ASEX) were filled before and 6 months after surgery by the male patients. The ASEX form was also completed by the partners before and 6 months after the procedure. The height and weight measurements and testosterone values were measured before and after surgery. A statistically significant difference was found between the preoperative and post-operative IIEF-5 scores of the patients (p = 0.000 < 0.01). There was also a statistically significant difference between the patients and their partners' preoperative and post-operative ASEX scores. We can conclude that the partners of men with preoperative erection complaints also experience sexual dysfunction, and with the post-operative decrease in or disappearance of erection complaints, the sexual function of both male patients and their partners improves.
Due to its high cost-effectiveness, intrauterine device (IUD) is one of the widely used contraception methods worldwide. Intravesical migration of an IUD via perforation of the uterus and bladder is very rare. Endoscopic approach is recommended in the treatment, but open surgery may also be needed rarely. In this report, we present the case of a 37-yearold female who was misdiagnosed radiologically with bladder stone, but later on, it was understood that an IUD migrated to the bladder and resulted in stone formation. Laser lithotripsy was performed, and the migrated IUD was unearthed. Removal of the IUD with cystoscopic forceps was unsuccessful. Postoperative pelvic computed tomography revealed that a part of the IUD was outside the bladder. At the next operation session, laparoscopic removal of the IUD was applied. The patient was followed up for 5 days with a Foley catheter and discharged after performing cystography, assuring us that the bladder contours were normal.Keywords Bladder . Bladder stone . Endoscopic surgical procedures . Intrauterine device migrations Case HistoryA 37-year-old female was admitted to our urology outpatient clinic with complaints of suprapubic pain, polyuria, and urgency for the past 8 months. From her medical history, we have been informed that despite administration of an intrauterine device (IUD) 6 years ago, she had ectopic pregnancy 4 years ago and therefore she was applied with laparoscopic salpingectomy in a tertiary health-care center, and doctors told her they removed the IUD at the same operation. Her family history was unremarkable and physical examination was normal. Abundant leukocytes, erythrocytes, and crystals were detected at urinalysis. An opacity of 1.5×2 cm in size was viewed in the pelvic region of the urinary tract X-ray. It was reported as a bladder stone at pelvic ultrasonography. Cystoscopic stone fragmentation was planned. However, at cystoscopic examination, it appeared that the opacity which was radiologically considered bladder stone was indeed an intravesical encrusted foreign body entering the bladder lumen from the posterior wall (Fig. 1). Laser lithotripsy was performed and the migrated IUD was unearthed. Removal of the IUD with cystoscopic forceps was attempted, but the IUD was stuck firmly to the bladder wall. Postoperative pelvic computed tomography (CT) revealed that about 1 cm of the IUD was outside the bladder (Fig. 2). At the next operation session, laparoscopic removal of the IUD that was not associated with the uterus anymore was applied. The patient was followed up for 5 days with a Foley catheter, and hematuria was not developed within this early postoperative period. The patient was discharged after performing cystography, assuring us that the bladder contours were normal. DiscussionIUD is a contraceptive method that is widely used worldwide because of its efficacy, reliability, economy, and
Objective It has been understood that COVID‐19, which has become a global pandemic in a short time, is a disease affecting multiple organs and systems. Some of the organs and systems affected by the disease also play a role in the pathophysiology of erectile dysfunction (ED), which led us to consider the possible effects of the disease on the erectile function. In this study, we aimed to evaluate changes in the erectile functions of patients with COVID‐19 among those that had previously diagnosed with mild and moderate ED in our urology outpatient clinic. Material and methods Eighty‐one patients aged 18–65 years who were confirmed to have COVID‐19 were included in the study. According to disease severity, these patients were divided into two groups as mild (non‐hospitalized, n = 60) and moderate (hospitalized but did not require intensive care, n = 21). The patients’ pre‐ and post‐disease scores in the five‐item International Index of Erectile Function (IIEF‐5) and hormone panel results were compared. Results The changes in the IIEF‐5 scores of the patients from the pre‐disease to the post‐disease period were statistically significant for both the mild and moderate groups (p < 0.05). When these changes were compared between the mild and moderate groups, the difference was not statistically significant (p = 0.156). There was also no statistically significant change in the testosterone, follicle‐stimulating, luteinizing, and prolactin hormone levels before and after the disease. Conclusion In this study, we determined that SARS‐CoV‐2 infection caused deterioration in existing ED in sexually active male individuals, regardless of the severity of the disease.
Hipospadias son yıllarda prevalansı giderek artan konjenital bir anomalidir. Şanlıurfa'da tek merkezde tübülarize insize plak üretroplasti (TİPU) yapılarak tedavi edilen 45 olguluk distal hipospadias serimizin sonuçlarını paylaştık. Gereç ve Yöntem: Hipospadias onarımları tek merkez devlet hastanesinde aynı klinikten uzmanlığını almış 2 adet ürolog tarafından gerçekleştirildi. Tüm hastalarda TİPU tekniği kullanıldı. Mesane kontraksiyonlarını ve anal kaşıntıyı azaltmak için hastanede kalış süresince hastalara düşük doz oksibutinin ve hidroksizin HCL 2 mg/mL verildi. Hastalar ortalama 9,3 (6-12) ay takip edildi.
Penile prosthesis implantation (PPI) is the final stage treatment in erectile dysfunction (ED). In this study, we planned to investigate the effect of PPI application on sexual functionality in the patients and their partners. After taking permission and consent for the study, from 20 male patients who were applied penile prosthesis due to ED between March 2013 and June 2018 and their partners, the couples were included in the study. Patients and partners filled in Arizona Sexual Experiences Scale (ASEX) form before PPI. After starting to use prosthesis, 20 patients and 19 partners were asked to fill in modified EDITS and ASEX form in the follow‐ups in the sixth month. Average age was 54.35 years for the patients and 43.84 for the partners. Although post‐PPI sexual satisfaction ratio was detected higher in female partners compared with the male patients, this difference was not statistically significant (p = .71). A significant recovery was also observed in total scale score, physiological stimulation, orgasm capacity and satisfaction scores in both groups after PPI. Penile prosthesis implantation is an operation providing high satisfaction for both the partner and the patient and is still one of the best options of ED.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.